𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

✍ Scribed by Walter Jonat; Felix Hilpert; Nicolai Maass

Publisher
Springer
Year
2005
Tongue
English
Weight
250 KB
Volume
56
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant aromatase inhibitor therapy for
Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data
✍ G. Grana πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract Tamoxifen is the established adjuvant treatment for postmenopausal women with hormone‐sensitive early breast cancer. However, the side‐effects associated with tamoxifen therapy have prompted a search for safer and potentially more effective endocrine agents. Results from randomized tria

Clinical use of aromatase inhibitors in
Clinical use of aromatase inhibitors in the treatment of breast cancers
✍ Andrea Manni πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 388 KB πŸ‘ 1 views

Estrogens are the major hormones supporting the growth of human breast cancer. Aromatization of androgen precursors in peripheral tissues, including the breast cancer itself, is the major source of estrogens in postmenopausal women. Therefore, inhibition of the aromatase enzyme offers an effective m

Use of aromatase inhibitors in postmenop
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer
✍ Roseman, Barry J.; Buzdar, Aman U.; Singletary, S. Eva πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 39 KB πŸ‘ 2 views

Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast